Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting

Pulmonary hypertension (PH) continues to present significant challenges to the medical community, both in terms of diagnosis and treatment. The advent of the updated 2022 European Society of Cardiology (ESC) and European Respiratory Society (ERS) guidelines has introduced pivotal changes that reflec...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory medicine and research 2024-11, Vol.86, p.101123, Article 101123
Main Authors: Boucly, Athénaïs, Bertoletti, Laurent, Fauvel, Charles, Dewavrin, Mélanie Gallant, Gerges, Christian, Grynblat, Julien, Guignabert, Christophe, Hascoet, Sébastien, Jaïs, Xavier, Jutant, Etienne-Marie, Lamblin, Nicolas, Meyrignac, Olivier, Riou, Marianne, Savale, Laurent, Tromeur, Cécile, Turquier, Ségolène, Valentin, Simon, Simonneau, Gérald, Humbert, Marc, Sitbon, Olivier, Montani, David
Format: Article
Language:English
Subjects:
Algorithms
Classification
Congresses as Topic
Definition
France - epidemiology
Guidelines
Hemodynamics
Humans
Hypertension, Pulmonary - diagnosis
Hypertension, Pulmonary - etiology
Hypertension, Pulmonary - physiopathology
Hypertension, Pulmonary - therapy
Practice Guidelines as Topic
Pulmonary hypertension
Societies, Medical - standards
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pulmonary hypertension (PH) continues to present significant challenges to the medical community, both in terms of diagnosis and treatment. The advent of the updated 2022 European Society of Cardiology (ESC) and European Respiratory Society (ERS) guidelines has introduced pivotal changes that reflect the rapidly advancing understanding of this complex disease. These changes include a revised definition of PH, updates to the classification system, and treatment algorithm. While these guidelines offer a critical framework for the management of PH, they have also sparked new discussions and questions. The 5th French Pulmonary Hypertension Network Meeting (Le Kremlin-Bicêtre, France, 2023), addressed these emergent questions and fostering a deeper understanding of the disease's multifaceted nature. These discussions were not limited to theoretical advancements but extended into the practical realms of patient management, highlighting the challenges and opportunities in applying the latest guidelines to clinical practice.
ISSN:2590-0412
2590-0412
DOI:10.1016/j.resmer.2024.101123